NEW YORK (GenomeWeb) – Biosensor firm Silicon Kinetics said today it is collaborating with Biosys Technologies, Tokyo University, and St. Marianna University School of Medicine in Japan on a screening project for lung cancer drugs.

Under the terms of the collaboration, the parties will use Silicon Kinetics' Molecular Interaction Kinetics-Mass Spectrometry (MIK-MS) technology to screen and rank inhibitors targeting lung cancer as part of a larger study investigating the progression of lung cancer in non-smoking adults, along with potential personalized treatments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

Sponsored by

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.